abstract |
The present invention provides antibodies that bind to the colony stimulating factor 1 receptor (CSF1R). The present invention also provides antibody heavy and light chains capable of forming antibodies that bind to CSF1R. The present invention provides polynucleotides encoding antibodies against CSF1R. Polynucleotides encoding antibody heavy and light chains are also provided. The present invention provides treatment methods using anti-CSF1R antibodies. Such methods include, but are not limited to, methods for treating rheumatoid arthritis, bone loss, and multiple sclerosis. |